down arrow

medmix AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH1129677105
CHF
10.62
-0.08 (-0.75%)

Dec 15

SWX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
IVF HARTMANN Holding AG
Straumann Holding AG
Medacta Group SA
COMET Holding AG
SKAN Group AG
Coltene Holding AG
Medartis Holding AG
Alcon AG
medmix AG
Metall Zug AG
Why is medmix AG ?
1
Weak Long Term Fundamental Strength with a -16.54% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.93 times
  • The company has been able to generate a Return on Equity (avg) of 3.30% signifying low profitability per unit of shareholders funds
2
Flat results in Jun 25
  • CASH AND EQV(HY) Lowest at CHF 108.4 MM
  • DEBT-EQUITY RATIO (HY) Highest at 50.02 %
  • NET SALES(Q) Lowest at CHF 225.4 MM
3
With ROE of -0.22%, it has a Very Expensive valuation with a 0.90 Price to Book Value
  • Over the past year, while the stock has generated a return of 20.45%, its profits have fallen by -150.8%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is medmix AG for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
medmix AG
20.68%
0.64
44.37%
Switzerland SMI
10.0%
0.63
15.85%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
3.15%
EBIT Growth (5y)
-16.54%
EBIT to Interest (avg)
4.02
Debt to EBITDA (avg)
1.93
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.62
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
5.43%
ROE (avg)
3.30%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.90
EV to EBIT
25.04
EV to EBITDA
7.11
EV to Capital Employed
0.92
EV to Sales
1.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.69%
ROE (Latest)
-0.22%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET PROFIT(HY)

Higher at CHF 4.28 MM

INTEREST COVERAGE RATIO(Q)

Highest at 906.38

RAW MATERIAL COST(Y)

Fallen by -11.08% (YoY

OPERATING PROFIT(Q)

Highest at CHF 42.6 MM

OPERATING PROFIT MARGIN(Q)

Highest at 18.9 %

-5What is not working for the Company
CASH AND EQV(HY)

Lowest at CHF 108.4 MM

DEBT-EQUITY RATIO (HY)

Highest at 50.02 %

NET SALES(Q)

Lowest at CHF 225.4 MM

PRE-TAX PROFIT(Q)

Fallen at -54.17%

NET PROFIT(Q)

Fallen at -55.95%

Here's what is working for medmix AG
Interest Coverage Ratio
Highest at 906.38
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit
Highest at CHF 42.6 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CHF MM)

Operating Profit Margin
Highest at 18.9 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Raw Material Cost
Fallen by -11.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for medmix AG
Net Sales
Lowest at CHF 225.4 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CHF MM)

Pre-Tax Profit
Fallen at -54.17%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CHF MM)

Net Profit
Fallen at -55.95%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CHF MM)

Cash and Eqv
Lowest at CHF 108.4 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 50.02 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."